Diagnostic utility of the insulin-to-C-peptide molar ratio in differentiating insulin autoimmune syndrome and exogenous insulin antibody syndrome from insulinoma - Quiz - MDSpire

Diagnostic utility of the insulin-to-C-peptide molar ratio in differentiating insulin autoimmune syndrome and exogenous insulin antibody syndrome from insulinoma

  • By

  • Yang Wang

  • Yiwen Liu

  • Jie Yu

  • Baodi Xing

  • Fan Ping

  • Wei Li

  • Lingling Xu

  • Ming Li

  • Huabing Zhang

  • Yuxiu Li

  • July 7, 2026

  • 0 min

Share

Original Source(s)

Diagnostic utility of the insulin-to-C-peptide molar ratio in differentiating insulin autoimmune syndrome and exogenous insulin antibody syndrome from insulinoma

  • by Yang Wang, Yiwen Liu, Jie Yu, Baodi Xing, Fan Ping, Wei Li, Lingling Xu, Ming Li, Huabing Zhang, Yuxiu Li

  • July 7, 2026

Related Content

Dynamic navigation-based precision cardiac rehabilitation via blood metabolomics: from risk stratification to real-time intervention optimization

Preoperative risk score for malignancy in Bethesda III thyroid nodules: a multicentre retrospective study

Correction: Impact of donor stress-induced hyperglycemia on early graft outcomes in simultaneous pancreas-kidney transplantation: a retrospective cohort study